search
for
 About Bioline  All Journals  Testimonials  Membership  News


Indian Journal of Pharmacology
Medknow Publications on behalf of Indian Pharmacological Society
ISSN: 0253-7613
EISSN: 0253-7613
Vol. 40, No. 3, 2008, pp. 111-113
Bioline Code: ph08037
Full paper language: English
Document type: Research Article
Document available free of charge

Indian Journal of Pharmacology, Vol. 40, No. 3, 2008, pp. 111-113

 en In vivo antimalarial activity of ethanolic leaf extract of Stachytarpheta cayennensis   check for this species in other resources
Okokon, Jude E; Ettebong, Ette & Antia, Bassey S

Abstract

Objective: To evaluate the in vivo antiplasmodial activity of the ethanol leaf extract of Stachytarpheta cayennensis   check for this species in other resources in the treatment of various ailment in Niger Delta region of Nigeria, in Plasmodium berghei infected mice.
Materials and Methods: The ethanolic leaf extract of Stachytarpheta cayennensis (90-270 mg/kg/day) was screened for blood schizonticidal activity against chloroquine sensitive Plasmodium berghei berghei in mice. The schizonticidal effect during early and established infections was investigated.
Result: Stachytarpheta cayennensis (90-270 mg/kg/day) exhibited significant (P < 0.05) blood schizonticidal activity both in 4-day early infection test and in established infection with a considerable mean survival time comparable to that of the standard drug, chloroquine, 5 mg/kg/day.
Conclusion: The leaf extract possesses significant (P < 0.05) antiplasmodial activity which confirms it′s use in folkloric medicine in the treatment of malaria.

Keywords
Antimalarial, malaria, Plasmodium berghei, Stachytarpheta cayennensis

 
© Copyright 2008 Indian Journal of Pharmacology.
Alternative site location: http://www.ijp-online.com

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil